1995
DOI: 10.1097/00000637-199502000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Topical Heparin Enhances Patency in a Rat Model of Arterial Thrombosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0
1

Year Published

1995
1995
2010
2010

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 25 publications
(13 citation statements)
references
References 0 publications
1
11
0
1
Order By: Relevance
“…Treating locally with an irrigating solution containing 100 U/ml of hep- arin was shown to prolong APTT in rats within 20 min after reperfusion was established. 18 In our study, where a similar local treatment was given, there was no prolongation of APTT 120 min after reperfusion. From the above, it can be suggested that there is a possibility of a short-lived hemorrhagic risk in a small animal such as the rat.…”
Section: Bleedingsupporting
confidence: 45%
See 2 more Smart Citations
“…Treating locally with an irrigating solution containing 100 U/ml of hep- arin was shown to prolong APTT in rats within 20 min after reperfusion was established. 18 In our study, where a similar local treatment was given, there was no prolongation of APTT 120 min after reperfusion. From the above, it can be suggested that there is a possibility of a short-lived hemorrhagic risk in a small animal such as the rat.…”
Section: Bleedingsupporting
confidence: 45%
“…These findings are in agreement with previous studies. 18,19,22 To get an antithrombotic effect similar to local heparin treatment, our study showed that a fairly high systemic dosis of heparin (200 U/kg) is needed. This is likely to cause hemostatic problems in a large percentage of patients needing microvascular surgery.…”
Section: Bleedingmentioning
confidence: 91%
See 1 more Smart Citation
“…Systemic infusions of heparin in some experimental models produce no improvement in skin flap survival over control solutions. 35 In practice, the authors use heparin topically as an irrigating solution at the site of microvascular thrombosis. Termed "low molecular weight heparin" (LMW heparin), this substance maintains inhibition of activated clotting factor X (factor Xa), while causing less elongation of clotting times (ptt).…”
Section: Pharmacotherapeutics: An Effort To Improve Free Flap Survivalmentioning
confidence: 99%
“…Expérimentalement, les résultats sont contradictoires, certains observent une diminution [16] du taux de thrombose postopératoire en ajoutant de l'héparine au sérum tandis que d'autres n'en retrouvent pas [17] (niveau III expérimental). Dans l'étude clinique prospective multicentrique de Khouri et al [3] (niveau III), l'adjonction d'héparine n'avait pas d'effet significatif sur le résultat des lambeaux.…”
Section: Auteursunclassified